ST. LOUIS, Jan. 5 /PRNewswire/ -- Biomedical Systems, a global provider of centralized diagnostic services to the clinical trial industry, recently announced the appointment of Dr. Pierre Maison-Blanche as their Chief Medical Officer. Dr. Maison-Blanche earned his MD in 1981 from the University of Paris and specialized in Cardiology at Lariboisire Hospital. For the past thirty years, Dr. Maison-Blanche has performed angiography and clinical research in the cardiovascular therapeutic area in the Cardiology Department at Lariboisiere Hospital. Dr. Maison-Blanche’s clinical specialty is non-invasive cardiac electrophysiology and he organized the first ECG Laboratory at Lariboisiere Hospital under the leadership of Dr. Philippe Coumel.
“I am extremely excited to be able to announce to our Sponsors that Dr. Maison-Blanche has joined Biomedical Systems,” said Kevin J. Klingler, President, Pharmaceutical Services. “Pierre has an impeccable reputation and will further strengthen Biomedical Systems position as the leader in centralized diagnostic services around the world.” Dr. Maison-Blanche, who will be based out of Paris, France, will provide consult and guidance to both the Corporate Headquarters in St. Louis, Missouri and the European Headquarters based in Brussels, Belgium. “Dr. Maison-Blanche is highly regarded internationally for his cardiac expertise,” said Dr. Tim Callahan, PhD, Biomedical Systems’ Chief Scientific Officer. “With the landscape of clinical trials constantly changing, it is imperative to have dedicated researchers like Dr. Maison-Blanche to help us maintain our focus on data quality which will allow our pharmaceutical Sponsors to bring more effective drugs to market in shorter timeframes.”
In addition to his duties as Biomedical Systems’ Chief Medical Officer, Dr. Maison-Blanche serves as a Consultant for Assistance Publique des Hopitaux de Paris. In 1998, Maison-Blanche established the Centralized ECG Services Department for MDS Pharma Services in Paris, France and chaired the MDS ECG Advisory Board from 2002 - 2006. Maison-Blanche has participated in several End of Phase II meetings with the Food and Drug Administration (FDA) as well as in Advisory Boards as an active member. He is currently a member and the Chairman of Data Monitoring Committees for on going trials.
Dr. Maison-Blanche is a highly sought after speaker and has published with leading journals around the world. He is a member of numerous professional societies and boards including the International Society for Holter and Noninvasive Electrocardiology.
Biomedical Systems is a global provider of centralized diagnostic services for the pharmaceutical and medical device industries. Corporate headquarters is based in St. Louis, Missouri with the European Headquarters located in Brussels, Belgium. Since 1975, Biomedical Systems has worked with over 11,000 investigative sites in 70 countries around the world for Phase I - IV clinical trials. Biomedical Systems centralized services include the acquisition, analysis and management of data for Cardiac Safety, Imaging and Pulmonary Function Testing.
For more information about Biomedical Systems, please contact Craig Pennington, Director of Marketing at 1-800-877-6334 (3179) or via email at cpennington@biomedsys.com . Additional information can be found on the company website at http://www.biomedsys.com .
Biomedical Systems
CONTACT: Craig Pennington, Director of Marketing for Biomedical Systems,+1-800-877-6334 (3179), cpennington@biomedsys.com
Web site: http://www.biomedsys.com/
